First human test of new Huntington's disease injection begins
NCT ID NCT06024265
Summary
This early study tested a new drug called ER2001, given by IV injection, in 10 adults with early Huntington's disease. The main goal was to check the safety of different doses and see how the drug moves through the body. Researchers also looked for early signs that the drug might be working to help control the disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HUNTINGTON DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
First Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, 510080, China
Conditions
Explore the condition pages connected to this study.